We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Pocket Laboratory Offers Fast and Reliable Diagnosis at Point of Care

By LabMedica International staff writers
Posted on 10 Apr 2023
Print article
Image: LabPad Evolution is a handheld PoC multi-measurements testing device (Photo courtesy of Biosynex)
Image: LabPad Evolution is a handheld PoC multi-measurements testing device (Photo courtesy of Biosynex)

A multi-technology, multi-parameters Point of Care (PoC) device combines two technologies in a single device for a unique evolutive panel of tests. The pocket-sized lab can perform multiple biological analyses from just a finger prick of blood and send the results via Bluetooth to a smartphone or tablet.

LabPad Evolution from Biosynex SA (Illkirch-Graffenstaden, France) is a handheld PoC device that healthcare professionals can use to perform multiple lab-quality measurements directly with patients. With its miniature automated microscope built from two CMOS sensors, the LabPad Evolution can carry out blood tests from a single finger prick. The device uses compatible single-use SmartChip tests that are available in two formats: Tsmart and Ksmart, each for different types of testing. Tsmart is intended for coagulation testing as INR, consisting of a microfluidic microcuvette embedding a dried or freeze-dried reagent (dry chemistry) while Ksmart is meant for lateral flow testing based on visual or fluorescent optical measurements. The LabPad Evolution automatically conducts internal quality controls before, during, and after each measurement, and displays an error message if any interference is detected.

LabPad Evolution can operate as a standalone tool, storing up to 1,000 results in its memory, which can be viewed on its screen. Additionally, the LabPad Evolution is fully connected and can transmit results automatically via USB or Bluetooth. It can integrate with information systems for centralized processes such as operator authorization/identification, patient identification, quality controls, and results validation/management. The current available SmartChip tests are for SARS-COV-2 Antigen, SARS-COV-2 Antibody, and TP/INR rapid tests. Future tests will focus on nutrition and cardiac markers.

Related Links:
Biosynex SA

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: The fastGEN BCR::ABL1 Cancer kit offers a way to personalize treatment strategies for leukemia (Photo courtesy of BioVendor MDx)

First of Its Kind NGS Assay for Precise Detection of BCR::ABL1 Fusion Gene to Enable Personalized Leukemia Treatment

The BCR::ABL1 fusion gene plays a key role in the pathogenesis of several blood cancers, particularly chronic myeloid leukemia (CML). This gene results from a chromosomal translocation that causes constitutive... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The new method is quick and easy, and can also be used by non-medical personnel. (Photo courtesy of Zoratto et al. Advanced Science 2024, edited)

New Blood Test Device Modeled on Leeches to Help Diagnose Malaria

Many individuals have a fear of needles, making the experience of having blood drawn from their arm particularly distressing. An alternative method involves taking blood from the fingertip or earlobe,... Read more